AMD, Ryzen AI Max

President Joe Biden’s administration plans one additional round of restrictions on the export of artificial intelligence ...
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
Good morning. Joe Biden takes one final stand to limit AI chip exports. Apple loses its latest plea to keep iPhones in ...
The AMD Ryzen AI Max and Ryzen AI Max PRO processors are scheduled for release in Q1 2025, alongside the Ryzen AI 300 Series.
AMD has launched new processors for AI PCs, gaming laptops, gaming handhelds, and workstations at CES 2025 in Vegas.
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...
HSBC just hit the brakes on the chipmaker, downgrading the stock from Buy to Reduce and slashing its price target from $200 to $110a move that signals a rocky road ahead. HSBC analyst Frank Lee didn't ...